Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation EuroPCR 2022

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Presenter: Felix Mahfoud

May 20, 2022

Presentation ACC 2019

Chemical Renal Denervation with Alcohol: The Post-Market Study Data and The Target BP Program

Presenter: Horst Sievert

March 18, 2019

Presentation TCT 2014

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

Presenter: Alexander Plehn

September 16, 2014

Presentation TCT 2014

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Ulrich Hink

September 13, 2014

Presentation TCT 2013

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Presenter: Murray Esler

October 29, 2013

Presentation TCT Russia 2013

Renal Denervation for Blood Pressure Control in Patients with Hypertension and Insulin Resistance

Presenter: Jan Kovac

June 09, 2013

Presentation TCT 2013

Renal Sympathetic Denervation - Inducing An Instantaneous And Persisting 24h Ambulatory Blood Pressure Drop In Patients With Resistant Hypertension – Results From The...

Presenter: Alexander Plehn, Sebastian Dietz, Konstantin Heinroth, Henning Lemm, Maria Leuthold, Silke Markau, Uwe Raaz, Therese Schubert, Alexander Vogt, Karl Werdan

January 31, 2013

Presentation TCT 2012

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

Presentation TCT 2012

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Presenter: Alexander Plehn

October 23, 2012

Advertisement

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Chemical Renal Denervation with Alcohol: The Post-Market Study Data and The Target BP Program

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Renal Denervation for Blood Pressure Control in Patients with Hypertension and Insulin Resistance

Renal Sympathetic Denervation - Inducing An Instantaneous And Persisting 24h Ambulatory Blood Pressure Drop In Patients With Resistant Hypertension – Results From The...

Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates?

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content